Healthcare -
Biotechnology - NASDAQ - US
$ 13.61
3.34 %
$ 1.54 B
Market Cap
-4.04
P/E
DYN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities DYN - Dyne Therapeutics, Inc.
83.3 M
LAST VALUE
61.37%
2 YEAR CAGR
262.24%
5 YEAR CAGR
-15.96%
10 YEAR CAGR